TELA Bio to Announce Third Quarter 2023 Financial Results
26 oct. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Oct. 26, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
18 sept. 2023 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions...
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
16 août 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Reports Second Quarter 2023 Financial Results
09 août 2023 16h03 HE
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 août 2023 16h02 HE
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
26 juil. 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., July 26, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options
15 juin 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., June 15, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Participate in the Jefferies Global Healthcare Conference
25 mai 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., May 25, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
19 mai 2023 07h00 HE
|
TELA Bio, Inc.
MALVERN, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical...
TELA Bio Reports First Quarter 2023 Financial Results
11 mai 2023 16h02 HE
|
TELA Bio, Inc.
MALVERN, Pa., May 11, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...